Skip nav

St Helier, Jersey/Douglas, Isle of Man – August 4, 2015 – Mann Bioinvest, the Isle of Man-headquartered specialist life science advisory company chaired by renowned investor Jim Mellon, has launched a new global investment fund focused on small-cap and private companies in the therapeutic sector.

Mann Bio Pathfinder IC (MBP)– is the firm’s second life sciences vehicle and will be managed by chief investment officer Andy Smith, whose track record in the sector is well established – Smith’s existing fund with Mann Bioinvest, the Magna Biopharma Income Fund (MBIF), is up over 50% in the 19 months since inception.


Read full release